Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

NCT05945563 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05945563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
January 17, 2023
Completion date
July 18, 2025
Enrollment
208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral aneurysm